RecruitingNCT06106516

Vital Sign Monitor Device Validation - WARD


Sponsor

Rigshospitalet, Denmark

Enrollment

1,000 participants

Start Date

Oct 24, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Aim: to assess the validity of CE/FDA approved vital sign monitor devices for clinical use in clinical setting. Patients: up to 1000 medical and/or surgical patients will be included Intervention: Studies with various wirless or novel vital sign monitor devices control: Golden standard measurements or clinical standard devices Outcome: Agreement assessed by bias and limits of agreement between Intervention and control device.


Eligibility

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEnovel vital sign monitor

Devices that are to be introduced into the clinic but where data from clinical relevant conditions such as complications are lacking to assess the validity under clinical conditions


Locations(2)

Eske Kvanner Aasvang

Copenhagen, Denmark

Bispebjerg Hospital

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06106516


Related Trials